Key result
Gallic acid reduced peak sodium current density in rat cardiomyocytes from -84.02 pA/pF to -44.20 pA/pF at 10 μmol/L and prolonged the onset of aconitine-induced fatal ventricular fibrillation.
Why the study?
Gallic acid has a protective effect on the cardiovascular system, but its cardiac electrophysiological effects required investigation.
Gallic acid demonstrates anti-arrhythmic potential by inhibiting voltage-gated sodium channels in rat cardiomyocytes and delaying aconitine-induced fatal ventricular fibrillation in vivo.
Answers are grounded in this paper and cite their sources.
Gallic acid may inhibit sodium currents in experimental models; leaves open any antiarrhythmic role in humans pending clinical data.
Gallic acid (GA) has a protective effect on the cardiovascular system. To study its cardiac electrophysiological effects, voltage‐gated Na + channel currents (I Na ) were recorded in rat cardiomyocytes using whole‐cell patch clamp techniques. Moreover, the effects of GA on aconitine‐induced arrhythmias were assessed using electrocardiograms in vivo. We found that the current–voltage characteristic curve (I‐V curve) of I Na significantly shifted in the presence of 1, 3, and 10 μmol/L of GA. The peak sodium current density ( I Na ‐Peak) was reduced from −84.02 ± 5.68 pA/pF to −65.78 ± 3.96 pA/pF with 1 μmol/L, −54.45 ± 5.18 pA/pF with 3 μmol/L, and −44.20 ± 4.35 pA/pF with 10 μmol/L, respectively. GA shifted the steady‐state activation curve of I Na and recovery curve to the right and the steady‐state inactivation curve to the left. The observed inhibitory effect was comparable to that of amiodarone. GA pre‐treatment significantly prolonged the onset of fatal ventricular fibrillation. Our results indicated that GA inhibited I Na in rat ventricular myocytes and aconitine‐induced arrhythmias in vivo. These results suggest the potential of GA for development as a novel anti‐arrhythmic therapeutic.
No takes yet. Share an insight, caveat, or question.
Du et al. (2020) studied Aconitine-induced arrhythmias. Gallic acid vs. Baseline was evaluated on Peak sodium current density (INa-Peak). Gallic acid reduced peak sodium current density in rat cardiomyocytes from -84.02 pA/pF to -44.20 pA/pF at 10 μmol/L and prolonged the onset of aconitine-induced fatal ventricular fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: